Answers are grounded in this paper and cite their sources.
, a capillary-driven microfluidic patch for noninvasive sweat collection to investigate paired sweat-blood analysis. Ten participants wear the patch during exercise; matched sweat and blood samples are analyzed by enzyme-linked immunosorbent assay (ELISA). The platform collects sweat within 30 min, with 100% success. CEA was detected in sweat and showed a disease-stage-associated trend; however, concentrations in healthy participants and survivors remained below the assay's lower limit of quantification, highlighting analytical sensitivity as a limitation. PIP was measurable in blood, with the highest level observed in Stage III disease, although several values exceeded the assay's validated upper limit, while remaining undetectable in sweat. Validation showed the patch recovers 65% of loaded fluid, and recovered eluate retains loaded CEA concentration (recovery 108%, 92%, and 98%), confirming sample handling does not deplete the analyte. These findings represent, to our knowledge, the first paired sweat-blood comparison of CEA and PIP using a passive capillary-driven wearable patch and establish analytical requirements, including sample volume, analyte recovery, assay sensitivity, and biomarker selection, for noninvasive sweat-based breast cancer monitoring.
No takes yet. Share an insight, caveat, or question.
Esmaeildoost et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: